|Basic InformationLatest News|Taking Opioids Before Knee Surgery Could Raise Pain LaterERs May Need to Rethink Opioid Prescription PracticesCommon Painkillers Tied to Slight Rise in Heart Attack RiskOpioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: Study'Mindfulness' Probably Won't Cure Your Back Pain: StudyExpectations, Concerns Vary With Age for Adults at Pain ClinicMusic May Soothe the 'Savage Beast' of Post-Op PainThis Fanged Fish Might Someday Help Ease Your PainSteroid Shots Offer No Long-Term Relief for Low-Back PainInitial Rx Can Affect Likelihood of Long-Term Opioid UseOpioid Dependence Can Start in Just a Few DaysOpioid Painkillers and Xanax or Valium a Deadly Mix: StudyDiazepam Not Beneficial for Acute Low Back Pain in ERKids' OD Risk Rises When Opioids Left Out at HomeChronic Pain More Likely for Poor, Less Educated: StudySome Docs May Help Fuel Opioid Abuse EpidemicTry Drug-Free Options First for Low Back Pain, New Guidelines SayTwelve Percent of Women Fill Opioid Rx After Vaginal DeliveryLow Back Pain? Relax, Breathe and Try YogaOpioids and Alcohol a Dangerous CocktailTreatment of Hips Beneficial in Patients With Low Back PainCommon Painkillers Don't Ease Back Pain, Study FindsHigh Pain Tolerance Tied to 'Silent' Heart Attack RiskWhat You Need to Know When Prescribed an Opioid PainkillerDiscussing Opioid Risks With Patients Reduces MisuseVitamin D Replacement Improves Chronic Widespread PainCelebrex May Not Pose Bigger Heart Risk Than Similar Drugs: StudyMany Take Opioids Reluctantly for Back Pain: Survey'Fake Pills' May Help Ease Back PainHealth Tip: Need Pain Relief?DEA Puts Quota on Production of Opioid PainkillersRisk of Opioid Addiction Up 37 Percent Among Young U.S. AdultsCould Prescribed NSAID Painkillers Raise Heart Failure Risk?Opioid Epidemic Costs U.S. $78.5 Billion Annually: CDCReview Suggests Safe, Effective Ways to Relieve Pain Without MedsFDA: Opioids Plus Sedatives Pose Fatal OD RiskNon-addictive Painkiller Shows Promise in Animal TrialsNighttime Sleep Disturbance Common in Chronic PainCannabis Provides More Pain Relief for Men Than WomenStudy Finds Links Between Chronic Pain, Depression in CouplesAddiction Risk Low for Seniors Taking Post-Op Opioids: StudyDoctors Urged to Prescribe Lower Doses of Opioids, No RefillsPain Raises Risk of Opioid AddictionCommon Surgeries Raise Risk for Opioid Dependence: StudyDoes Medical Marijuana Reduce Need for Other Meds?Programs to Spot Painkiller Abuse Work, But Are UnderusedTighter Opioid Laws in U.S. Haven't Eased MisuseLong-Acting Opioids May Increase Risk of All-Cause MortalityOpioid Painkillers Raise Deadly Heart Risks for Some: StudyPatients Often Prescribed Extra Painkillers, Many Share ThemQuestions and AnswersLinks
Cannabis Provides More Pain Relief for Men Than Women
Updated: Aug 24th 2016
WEDNESDAY, Aug. 24, 2016 (HealthDay News) -- Men seem to exhibit greater cannabis-induced analgesia relative to women, according to a study published online Aug. 5 in Drug and Alcohol Dependence.
Ziva D. Cooper, Ph.D., and Margaret Haney, Ph.D., of the New York State Psychiatric Institute and Department of Psychiatry at the Columbia University Medical Center in New York City, asked 42 recreational cannabis smokers to place one hand in extremely cold water until they could no longer tolerate the pain. They did this twice: Once after smoking cannabis and once after smoking a placebo.
The researchers found that after smoking cannabis, men reported they were significantly less sensitive to pain. They were also more able tolerate pain. While women reported they were somewhat more able to tolerate pain after smoking cannabis, it brought them no significant pain relief. Despite the differences in pain relief, men and women had similar levels of intoxication after smoking cannabis.
"This study underscores the importance of including both men and women in clinical trials aimed at understanding the potential therapeutic and negative effects of cannabis, particularly as more people use cannabinoid products for recreational or medical purposes," Cooper said in a university news release.
Cooper has received funding from INSYS Therapeutics and is a consultant to KannaLife Sciences and PharmaCann. Haney has received funding from INSYS Therapeutics and Aelis Farma. The companies are commercial sellers of medical marijuana.
Full Text (subscription or payment may be required)
This article: Copyright © 2016 HealthDay. All rights reserved.